Shares of Moderna rose 7.97% to $106.42 at 14:14 EST on Wednesday, after consecutive sessions in a row of losses. The Nasdaq Stock Market is jumping 0.04% to $11,895.20, after two successive sessions in a row of losses, on what up until now seems, a somewhat positive trend trading session today.
European commission announces vaccine-supply deal with Moderna. According to yesterday’s article on ForexLive, “The contract will see Moderna supply up to 160 million doses of its coronavirus vaccine to the EU
For some context of the size of that deal, Italy’s adult population is estimated to be somewhere around 60 million people..”
Year-on-year quarterly revenue growth declined by 0%, now sitting on for the twelve trailing months.
Moderna’s stock is valued at $106.42 at 14:14 EST, higher than its 52-week high of $0.00.
Moderna’s value is above its 50-day moving average of $0.00 and higher than its 200-day moving average of $0.00.